Search Results 151-160 of 14429 for albumin

1. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

   ... albumin ≥ 3.0 g/dL;; Hepatic function for subjects with liver metastases: bilirubin ≤ 1.5 × ULN, AST, ALT, and GGT ≤ 5.0 × ULN, and albumin ≥ 3.0 g/dL.

2. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

   Albumin < 3.5 g/dL. International normalized ratio (INR) ≥ 1.7. Current or history of significant alcohol consumption for a period of more than 3 ...

3. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors - Mayo Clinic

   Albumin ≥ 2.8 g/dL. Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3.0 x ULN. No known central nervous system metastases unless ...

4. Sonocloud-9 In Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU Or TMZ) In Recurrent GBM - Mayo Clinic

   ... albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. Sonabend AM. Adam M; Gould A. Andrew; Amidei C. Christina; Ward R. Rachel ...

5. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC - Mayo Clinic

   serum albumin > 3.5 gm/dl;; serum total bilirubin < 1.5 mg/dl;; alanine aminotransferase (ALT)/ aspartate aminotransferase (AST)/ alkaline phosphatase < 2 x ...

6. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Calcium ≥ LLN (corrected for serum albumin, if albumin abnormal);; Magnesium ≥ LLN;; Sodium ≥ LLN;; Phosphorus ≥ LLN. NOTE: Supplementation may be given ...

7. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia) - Mayo Clinic

   Serum albumin ≥3.2 g/dL (or ≥32 g/L) in the absence of receipt of IV albumin within the previous 72 hours. • Bilirubin ≤1.5 mg/dL. • Aspartate ...

8. A Study of Measurement of Renal Viscoelastic Properties with Ultrasound - Mayo Clinic

   Patients with a positive diagnosis of chronic kidney disease with an estimated glomerular filtration rate of less than 90 and an albumin/creatinine ration of ...

9. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

   Serum albumin ≥3.0 g/dL. Last dose of any prior therapy administered by the following time intervals before the first dose of study drug: Chemotherapy ...

10. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    Albumin >= 2 g/dL. Left ventricular ejection fraction (LVEF) >= 53% (or institutional normal; if the LVEF result is given as a range of values, then the ...